Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease by Jennifer L. Whitwell, Stephen D. Weigand, Maria M. Shiung,

Slides:

Advertisements

Similar presentations

VBM Voxel-based morphometry

Advertisements

By: Tracy Ssali Medical Biophysics 3970z April 4 th 2012 Supervisors: Keith St. Lawrence, PhD Udunna Anazodo, PhD candidate.

Agenda: - Update on master tracers’ segmentation check - Update validation vs pathology - PMT application submission of “Study on the validation of VSRAD”

Connectivity between MS lesion density and cortical thickness Keith Worsley Arnaud Charil Jason Lerch Department of Mathematics and Statistics, McConnell.

Dementia with Lewy Bodies

MNTP Trainee: Georgina Vinyes Junque, Chi Hun Kim Prof. James T. Becker Cyrus Raji, Leonid Teverovskiy, and Robert Tamburo.

HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.

Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.

SLICER: Initial Experience at Dartmouth Tara McHugh, M.A. Robert Roth, Ph.D. Brain Imaging Laboratory Dartmouth Medical School / DHMC NA-MIC National Alliance.

Brain Atrophy in Type 2 Diabetes Regional distribution and influence on cognition Featured Article: Chris Moran, M.B., B.C.H., Thanh G. Phan, P.H.D., Jian.

Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.

The role of the ventrolateral frontal cortex in inhibitory oculomotor control by Tim Hodgson, Marcia Chamberlain, Benjamin Parris, Martin James, Nicholas.

CHANGES IN BRAIN MORPHOLOGY ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA Mary J. Morrell et al Presented by Karen Hu PSYCH 260.

Structural MRI as a Biomarker of Disease Progression in AD Department of Diagnostic Radiology and MRI Research Lab Presented by Clifford Jack, M.D. at.

Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Fig. 1 The effects of modelling global volume for the analysis of PDD relative to controls. Atrophy in PDD shown (A) compensated for differences in head.

Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy Kelvin Leung, Casper.

Distribution of Zn isotopes during Alzheimer’s disease

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease Dement Geriatr Cogn Disord.

Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,

A 66 year-old woman with progressive speech difficulty

20 Years of FreeSurfer PETsurfer: MRI-PET Integration using FreeSurfer Nov 17, 2017 Douglas N. Greve, Ph.D. Martinos Center for Biomedical Imaging Massachusetts.

Syntactic Processing Depends on Dorsal Language Tracts

Volume 17, Issue 5, Pages (October 2016)

Neurodegenerative Diseases Target Large-Scale Human Brain Networks

Christian Mayer, Rachel C. Bandler, Gord Fishell Neuron

Volume 81, Issue 6, Pages (March 2014)

Michael S Beauchamp, Kathryn E Lee, Brenna D Argall, Alex Martin

A Network Diffusion Model of Disease Progression in Dementia

The Human Hippocampus and Spatial and Episodic Memory

Fig. 1. [11C]Martinostat images of all subjects show high cortical binding and distinct gray-white matter differences. [11C]Martinostat images of all subjects.

Volume 63, Issue 2, Pages (July 2009)

Volume 41, Issue 5, Pages (March 2004)

Volume 76, Issue 5, Pages (December 2012)

Neural Mechanisms of Hierarchical Planning in a Virtual Subway Network

Volume 77, Issue 2, Pages (January 2013)

Box and Whisker Plot of the Distribution of Perceived Stress Scores for TMD Controls and TMD CasesThe horizontal line within the box is the median value.

Statistical Challenges in “Big Data” Human Neuroimaging

Syntactic Processing Depends on Dorsal Language Tracts

Biomarker Modeling of Alzheimer’s Disease

Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L

Acute Effects of Cocaine on Human Brain Activity and Emotion

Michael S Beauchamp, Kathryn E Lee, Brenna D Argall, Alex Martin

The MR scan of brain of our case vignette patient showing significant occipital lobe atrophy (especially left sided) with parietal lobe involvement as.

Volume 74, Issue 4, Pages (May 2012)

The Future of Memory: Remembering, Imagining, and the Brain

Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M

Baseline Characteristics of the Subjects

Christian Mayer, Rachel C. Bandler, Gord Fishell Neuron

Volume 81, Issue 6, Pages (March 2014)

A side-by-side comparison of EPVS in a cognitively healthy control versus a patient with aMCI A, A coronal MR brain image of a cognitively healthy control.

Effects of Lexicality, Frequency, and Spelling-to-Sound Consistency on the Functional Anatomy of Reading Julie A. Fiez, David A. Balota, Marcus E. Raichle,

Volume 24, Issue 1, Pages (July 2018)

Axial 123I-FP-CIT DaT-SPECT images in a patient with dementia with Lewy bodies (A) and a patient with Alzheimer disease (B). Axial 123I-FP-CIT DaT-SPECT.

[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β.

Figure 2 Global tau-PET distribution in familial prion disease mirrors the distribution seen in Alzheimer disease Global tau-PET distribution in familial.

Volume 76, Issue 5, Pages (December 2012)

VBM results for differences in WM volume between patients with POAG and disease-free control subjects. VBM results for differences in WM volume between.

A Hippocampal Marker of Recollection Memory Ability among Healthy Young Adults: Contributions of Posterior and Anterior Segments Jordan Poppenk, Morris.

Volume 63, Issue 2, Pages (July 2009)

Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.

Figure 4 Patient 3 MRI evolution over time

A, effect of IP6 feeding on the weight of LUT organs normalized to body weight. A, effect of IP6 feeding on the weight of LUT organs normalized to body.

Regions showing progression of GM atrophy during a 9-month period90 in 16 patients with ALS compared with 10 controls (red) and regions showing additional.

A–C, Schematic representations of experimental timeline (A) and MRI data processing (B, C). A–C, Schematic representations of experimental timeline (A)

A comparison of coronal T1 MRI scans showing relative atrophy within the hippocampus/temporal lobe in an AD subject (left) compared with a DLB subject.

by Andrew W. Kraft, Adam Q. Bauer, Joseph P. Culver, and Jin-Moo Lee

Boxplots of diffusion (A and B) and perfusion (C) characteristics in brain metastases (gray), glioblastomas (white), and PCLs (dotted). Boxplots of diffusion.

Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis The rate.

Presentation transcript:

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease by Jennifer L. Whitwell, Stephen D. Weigand, Maria M. Shiung, Bradley F. Boeve, Tanis J. Ferman, Glenn E. Smith, David S. Knopman, Ronald C. Petersen, Eduardo E. Benarroch, Keith A. Josephs, and Clifford R. Jack Brain Volume 130(3): March 8, 2007 © 2007 The Author(s)‏

Coronal slices of the unsmoothed customized template image showing the location of the four ROI used in the VBM-based ROI analysis. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Three-dimensional surface renders showing the patterns of cortical GM loss in the DLB, and Alzheimer's disease groups, compared with controls (corrected for multiple comparisons, P < 0.05). Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Patterns of GM loss in the DLB and Alzheimer's disease groups compared with controls (corrected for multiple comparisons, P < 0.05), overlaid on the unsmoothed customized template. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Regions showing significantly greater GM loss in the Alzheimer's disease group than the DLB group (corrected for multiple comparisons, P < 0.05), overlaid on the unsmoothed customized template. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Box-plots of each patient's average VBM-based modulated GM density per voxel for four ROI. The horizontal lines of the boxes represent the 25th, 50th (median) and 75th percentiles of the distributions. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Box-plots showing the hippocampal and SI volumes measured from the volumetric MRI for each subject. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏

Schematic diagram showing the location of cholinergic, serotonergic and noradrenergic neurons in the brainstem and basal forebrain. Jennifer L. Whitwell et al. Brain 2007;130: © 2007 The Author(s)‏